4 most recent filings and news items mentioning LH. Updated every 60 seconds.
Earnings|Guidance|BuybackJul 30, 2026Neutral
Labcorp beat quarterly earnings expectations and raised 2026 guidance, citing growth in core business and oncology. The company announced a $1.0 billion increase in its share repurchase program.
View filing at SEC.gov →
DividendJul 10, 2026Neutral
Labcorp's board approved a quarterly cash dividend of $0.72 per share payable on September 11. This announcement underscores the company's continued commitment to returning capital to shareholders.
View filing at SEC.gov →
EarningsJun 30, 2026Neutral
Labcorp will release its second quarter 2026 financial results on July 30. This announcement provides market participants with the specific timing to anticipate key financial disclosures and guidance.
View filing at SEC.gov →
OtherMay 27, 2026Neutral
Labcorp will present at the 2026 Jefferies Global Healthcare Conference in New York on June 3, with a live webcast available on its investor relations website. The presentation is a routine investor engagement activity with no material business impact.
View filing at SEC.gov →
AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.